Akari Therapeutics Plc (AKTX) Social Stream

Akari Therapeutics Plc (AKTX): $0.95

0.01 (+1.06%)

POWR Rating

Component Grades













Add AKTX to Watchlist
Sign Up

Industry: Biotech


of 496

in industry

Akari Therapeutics Plc (AKTX) Price Targets From Analysts

Use the tables below to see what analysts covering Akari Therapeutics Plc think about its future price and what recommendations they have for investors and traders.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
1 $5 $5 $5 $1.66 201.2%

Price Target Last Issued July 9, 2020

AKTX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for AKTX as an investment opportunity.

  • Akari Therapeutics Plc's number of analysts covering the stock is higher than just about none of of all US stocks.
  • AKTX has a less variance in analysts' estimates than just about 100% of all US stocks.
  • The upside potential (average analyst target price relative to current price) of AKTX is higher than 97.51% of stocks in the mid market cap category.
  • The average analyst price target of AKTX is greater than 3.49% of stocks in the mid market cap category.

Make investment decisions regarding AKTX using the data that counts. Try POWR Ratings for free.

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.8019 seconds.